Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-032851

IDERA PHARMACEUTICALS, INC. · IDRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Youssef El Zein
Director · 10% Owner
Pillar Pharmaceuticals I LP
Director · 10% Owner
Pillar Invest Corp
Director · 10% Owner
Period of report
Nov 3, 2016
Accepted (ET)
Nov 7, 2016 · 5:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F1Nov 3, 2016X1,370,000$0.00A0ISee Footnotes

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
WarrantsF1,F2$1.46Nov 3, 2016X1,370,000DNov 4, 2011Nov 4, 2016Common Stock1,370,0000I

Explanation of responses